GL Pharm Tech Corp. (KOSDAQ:204840)
4,230.00
+25.00 (0.59%)
At close: Aug 24, 2026
GL Pharm Tech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 65,219 | 84,606 | 75,097 | 70,834 | 46,578 | 76,699 | |
Market Cap Growth | -27.69% | 12.66% | 6.02% | 52.08% | -39.27% | 12.04% |
Enterprise Value | 82,638 | 99,657 | 82,885 | 82,845 | 55,794 | 82,225 |
Last Close Price | 4205.00 | 5455.00 | 4885.00 | 5680.00 | 3750.00 | 6200.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 6774.45 | - | - | - | - |
PS Ratio | 1.71 | 2.40 | 2.88 | 2.72 | 2.78 | 6.17 |
PB Ratio | 3.28 | 4.25 | 3.82 | 5.77 | 2.90 | 4.39 |
P/TBV Ratio | 3.52 | 4.36 | 3.98 | 6.18 | 3.10 | 4.92 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.16 | 2.83 | 3.18 | 3.18 | 3.34 | 6.62 |
EV/EBITDA Ratio | 50.23 | 78.44 | - | - | - | - |
EV/EBIT Ratio | 161.96 | 371.20 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.05 | 0.94 | 0.75 | 1.45 | 0.86 | 0.45 |
Debt / EBITDA Ratio | 15.36 | 14.75 | - | - | - | - |
Net Debt / Equity Ratio | 0.88 | 0.79 | 0.53 | 1.11 | 0.58 | 0.10 |
Net Debt / EBITDA Ratio | 12.82 | 12.36 | -180.25 | -12.52 | -8.35 | -2.53 |
Net Debt / FCF Ratio | -5.20 | -3.63 | -2.06 | -3.15 | -1.20 | -0.47 |
Asset Turnover | 0.82 | 0.77 | 0.63 | 0.65 | 0.46 | 0.37 |
Inventory Turnover | 2.16 | 2.15 | 2.08 | 2.86 | 2.67 | 2.83 |
Quick Ratio | 0.46 | 0.48 | 0.74 | 0.81 | 0.79 | 2.02 |
Current Ratio | 0.98 | 1.01 | 1.37 | 1.35 | 1.24 | 2.73 |
Return on Equity (ROE) | -0.54% | 0.06% | -14.63% | -26.42% | -4.71% | -23.49% |
Return on Assets (ROA) | 0.30% | 0.37% | -2.69% | -5.00% | -5.59% | -5.06% |
Return on Invested Capital (ROIC) | 0.60% | 0.13% | -6.31% | -12.59% | -14.62% | -14.63% |
Return on Capital Employed (ROCE) | 0.80% | 1.00% | -6.20% | -11.70% | -11.70% | -10.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -0.16% | 0.01% | -3.11% | -5.29% | -1.70% | -4.86% |
FCF Yield | -5.13% | -5.11% | -6.71% | -6.13% | -16.55% | -4.69% |
Buyback Yield / Dilution | -71.51% | -2.29% | -21.16% | -0.34% | -21.96% | -13.03% |